174 related articles for article (PubMed ID: 36754044)
1. Alkaloids in Withania somnifera (L.) Dunal Root Extract Contribute to Its Anti-Inflammatory Activity.
Orrù A; Marchese G; Ruiu S
Pharmacology; 2023; 108(3):301-307. PubMed ID: 36754044
[TBL] [Abstract][Full Text] [Related]
2. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
3. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
4. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.
Liu X; Chen C; Lin Y; Liu Y; Cai S; Li D; Li L; Xiao P; Yi F
J Ethnopharmacol; 2024 Apr; 323():117699. PubMed ID: 38185262
[TBL] [Abstract][Full Text] [Related]
5. Withanolides from Withania somnifera Ameliorate Neutrophil Infiltration in Endotoxin-Induced Peritonitis by Regulating Oxidative Stress and Inflammatory Cytokines.
Balkrishna A; Solleti SK; Singh H; Sharma N; Varshney A
Planta Med; 2022 May; 88(6):466-478. PubMed ID: 33862643
[TBL] [Abstract][Full Text] [Related]
6. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
7. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
8. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
9.
Holvoet H; Long DM; Law A; McClure C; Choi J; Yang L; Marney L; Poeck B; Strauss R; Stevens JF; Maier CS; Soumyanath A; Kretzschmar D
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235577
[No Abstract] [Full Text] [Related]
10. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
11. Exploration of immunomodulatory and protective effect of Withania somnifera on trace metal oxide (zinc oxide nanoparticles) induced toxicity in Balb/c mice.
Kumar J; Mitra MD; Hussain A; Kaul G
Mol Biol Rep; 2019 Apr; 46(2):2447-2459. PubMed ID: 30847852
[TBL] [Abstract][Full Text] [Related]
12. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
13. Effect of Withania somnifera Dunal Root Extract on Behavioral Despair Model in Mice: a Possible Role for Nitric Oxide.
Attari M; Jamaloo F; Shadvar S; Fakhraei N; Dehpour AR
Acta Med Iran; 2016 Mar; 54(3):165-72. PubMed ID: 27107520
[TBL] [Abstract][Full Text] [Related]
14. Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.
Saggam A; Tillu G; Dixit S; Chavan-Gautam P; Borse S; Joshi K; Patwardhan B
J Ethnopharmacol; 2020 Jun; 255():112759. PubMed ID: 32173425
[TBL] [Abstract][Full Text] [Related]
15. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors.
Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
[TBL] [Abstract][Full Text] [Related]
17. Withania frutescens (L.) Pauquy, a valuable Mediterranean shrub containing bioactive withanolides.
Bouissane L; Bailly C
Steroids; 2024 Jul; 207():109439. PubMed ID: 38740121
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study.
M M; Zameer F; Naidu A; M N NP; Dhananjaya BL; Hegdekatte R
Pharm Biol; 2016 Sep; 54(9):1936-41. PubMed ID: 26704448
[TBL] [Abstract][Full Text] [Related]
19. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
20.
Lee DH; Ahn J; Jang YJ; Seo HD; Ha TY; Kim MJ; Huh YH; Jung CH
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32046183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
